Novo CEO pressed by Senate to cut price ranges of being overweight, diabetic issues medicines CEO Lars Fruergaard Jørgensen advised lawmakers the company would think about new talks with insurers regarding the list charges of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies. https://beckettkashb.blogunteer.com/29891175/the-2-minute-rule-for-healthcare-news